Priority Date: 15.03.12 (US 201261611342P)

COMBINATION OF A MC1R RECEPTOR AGONIST AND UVB FOR THE TREATMENT AND/OR PREVENTION OF PIGMENTATION DISORDERS

  • Application ID: EP13709912
  • Status: GRANT OF PATENT INTENDED

Applicant

Technology company logo small
Technology Company

Attorney

Employment test 11 - 50 employees
Company dna casalonga and partners
operating since 1867
Headquarter in Paris and 3 offices
active in Legal Services, IP Consulting, and Matchmaking and Trading

Specialization

This patent has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) Casalonga & Partners is specialized in A61. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 15.03.2012 - Priority Date (US 201261611342P)
  • 19.09.2013 - Publication A1 (WO2013135880)
  • 21.01.2015 - Publication A1 (EP2825187)